• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对继发性甲状旁腺功能亢进症的治疗侧重于甲状旁腺切除术。

Treatment for secondary hyperparathyroidism focusing on parathyroidectomy.

机构信息

Department of Transplant and Endocrine Surgery, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.

出版信息

Front Endocrinol (Lausanne). 2023 Apr 20;14:1169793. doi: 10.3389/fendo.2023.1169793. eCollection 2023.

DOI:10.3389/fendo.2023.1169793
PMID:37152972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10159274/
Abstract

Secondary hyperparathyroidism (SHPT) is a major problem for patients with chronic kidney disease and can cause many complications, including osteodystrophy, fractures, and cardiovascular diseases. Treatment for SHPT has changed radically with the advent of calcimimetics; however, parathyroidectomy (PTx) remains one of the most important treatments. For successful PTx, removing all parathyroid glands (PTGs) without complications is essential to prevent persistent or recurrent SHPT. Preoperative imaging studies for the localization of PTGs, such as ultrasonography, computed tomography, and Tc-Sestamibi scintigraphy, and intraoperative evaluation methods to confirm the removal of all PTGs, including, intraoperative intact parathyroid hormone monitoring and frozen section diagnosis, are useful. Functional and anatomical preservation of the recurrent laryngeal nerves can be confirmed intraoperative nerve monitoring. Total or subtotal PTx with or without transcervical thymectomy and autotransplantation can also be performed. Appropriate operative methods for PTx should be selected according to the patients' need for kidney transplantation. In the case of persistent or recurrent SHPT after the initial PTx, localization of the causative PTGs with autotransplantation is challenging as causative PTGs can exist in the neck, mediastinum, or autotransplanted areas. Additionally, the efficacy and cost-effectiveness of calcimimetics and PTx are increasingly being discussed. In this review, medical and surgical treatments for SHPT are described.

摘要

继发性甲状旁腺功能亢进症(SHPT)是慢性肾脏病患者的一个主要问题,可导致许多并发症,包括骨营养不良、骨折和心血管疾病。随着钙敏感受体激动剂的出现,SHPT 的治疗发生了根本性的变化;然而,甲状旁腺切除术(PTx)仍然是最重要的治疗方法之一。为了成功进行 PTx,必须切除所有甲状旁腺(PTGs)而不产生并发症,以防止持续性或复发性 SHPT。术前用于定位 PTGs 的影像学研究,如超声、计算机断层扫描和 Tc-Sestamibi 闪烁扫描,以及用于确认切除所有 PTGs 的术中评估方法,包括术中完整甲状旁腺激素监测和冷冻切片诊断,都是有用的。术中神经监测可确认喉返神经的功能和解剖保留。可以进行全或次全 PTx 联合经颈胸腺切除术和自体移植,也可以进行。根据患者对肾移植的需求,应选择适当的 PTx 手术方法。在初始 PTx 后出现持续性或复发性 SHPT 的情况下,由于致病的 PTGs 可能存在于颈部、纵隔或自体移植区域,因此定位致病的 PTGs 并进行自体移植具有挑战性。此外,钙敏感受体激动剂和 PTx 的疗效和成本效益也越来越受到关注。在这篇综述中,描述了 SHPT 的内科和外科治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3860/10159274/d0bf1952ea3e/fendo-14-1169793-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3860/10159274/e7a472dc3393/fendo-14-1169793-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3860/10159274/d0bf1952ea3e/fendo-14-1169793-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3860/10159274/e7a472dc3393/fendo-14-1169793-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3860/10159274/d0bf1952ea3e/fendo-14-1169793-g002.jpg

相似文献

1
Treatment for secondary hyperparathyroidism focusing on parathyroidectomy.针对继发性甲状旁腺功能亢进症的治疗侧重于甲状旁腺切除术。
Front Endocrinol (Lausanne). 2023 Apr 20;14:1169793. doi: 10.3389/fendo.2023.1169793. eCollection 2023.
2
Intraoperative intact parathyroid hormone monitoring and frozen section diagnosis are essential for successful parathyroidectomy in secondary hyperparathyroidism.术中甲状旁腺激素完整监测及冰冻切片诊断对于继发性甲状旁腺功能亢进症甲状旁腺切除术的成功至关重要。
Front Med (Lausanne). 2022 Nov 7;9:1007887. doi: 10.3389/fmed.2022.1007887. eCollection 2022.
3
Total parathyroidectomy without autotransplantation for renal hyperparathyroidism: experience with a qPTH-controlled protocol.无自体移植的甲状旁腺全切除术治疗肾性甲状旁腺功能亢进:基于快速甲状旁腺素控制方案的经验
World J Surg. 2006 May;30(5):743-51. doi: 10.1007/s00268-005-0379-0.
4
Endoscopic total parathyroidectomy and partial parathyroid tissue autotransplantation for patients with secondary hyperparathyroidism: a new surgical approach.内镜下全甲状旁腺切除术及部分甲状旁腺组织自体移植治疗继发性甲状旁腺功能亢进患者:一种新的手术方法。
World J Surg. 2009 Aug;33(8):1674-9. doi: 10.1007/s00268-009-0086-3.
5
Predictive value of characteristics of resected parathyroid glands for persistent secondary hyperparathyroidism during parathyroidectomy.甲状旁腺切除术后甲状旁腺特征对持续性继发性甲状旁腺功能亢进的预测价值。
BMC Surg. 2023 Feb 14;23(1):36. doi: 10.1186/s12893-023-01936-5.
6
Pre-operative Localisation of the Parathyroid Glands in Secondary Hyperparathyroidism: A Retrospective Cohort Study.继发性甲状旁腺功能亢进症甲状旁腺术前定位:回顾性队列研究。
Sci Rep. 2019 Oct 10;9(1):14634. doi: 10.1038/s41598-019-51265-y.
7
Maximal parathyroid gland diameter as a predictive factor for autograft-dependent recurrent secondary hyperparathyroidism after total parathyroidectomy.甲状旁腺最大径作为全甲状旁腺切除术后自体移植依赖性复发性甲状旁腺功能亢进的预测因素。
Front Endocrinol (Lausanne). 2023 Jun 15;14:1175237. doi: 10.3389/fendo.2023.1175237. eCollection 2023.
8
Intact parathyroid hormone levels localize causative glands in persistent or recurrent renal hyperparathyroidism: A retrospective cohort study.甲状旁腺激素水平完整可定位持续性或复发性肾性甲状旁腺功能亢进的致病腺体:一项回顾性队列研究。
PLoS One. 2021 Apr 1;16(4):e0248366. doi: 10.1371/journal.pone.0248366. eCollection 2021.
9
Persistent and recurrent hyperparathyroidism after total parathyroidectomy with autotransplantation.甲状旁腺全切并自体移植术后持续性及复发性甲状旁腺功能亢进
Ann Surg. 2002 Jan;235(1):99-104. doi: 10.1097/00000658-200201000-00013.
10
[Re-operation treatment in uremic patients complicated with persistent secondary hyperparathyroidism after parathyroidectomy with autotransplantation].甲状旁腺切除并自体移植术后尿毒症患者合并持续性继发性甲状旁腺功能亢进的再次手术治疗
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Jan 20;32(2):142-147. doi: 10.13201/j.issn.1001-1781.2018.02.016.

引用本文的文献

1
Parathyroidectomy Positively Modulates Systemic Inflammation and Nutritional Status: Immune-Inflammation Index and Prognostic Nutritional Index in Primary Hyperparathyroidism.甲状旁腺切除术对全身炎症和营养状况具有正向调节作用:原发性甲状旁腺功能亢进症中的免疫炎症指数和预后营养指数
Medicina (Kaunas). 2025 Jul 8;61(7):1236. doi: 10.3390/medicina61071236.
2
Predictors of Hungry Bone Syndrome and Reintervention After Subtotal Versus Total Parathyroidectomy for Secondary Hyperparathyroidism in Dialysis Patients: A Single-Center Cohort.透析患者继发性甲状旁腺功能亢进行甲状旁腺次全切除术与全切除术后饥饿骨综合征及再次干预的预测因素:一项单中心队列研究
J Clin Med. 2025 Jul 12;14(14):4944. doi: 10.3390/jcm14144944.
3

本文引用的文献

1
Intraoperative intact parathyroid hormone monitoring and frozen section diagnosis are essential for successful parathyroidectomy in secondary hyperparathyroidism.术中甲状旁腺激素完整监测及冰冻切片诊断对于继发性甲状旁腺功能亢进症甲状旁腺切除术的成功至关重要。
Front Med (Lausanne). 2022 Nov 7;9:1007887. doi: 10.3389/fmed.2022.1007887. eCollection 2022.
2
Retrospective real-life study on preoperative imaging for minimally invasive parathyroidectomy in primary hyperparathyroidism.原发性甲状旁腺功能亢进症微创甲状旁腺切除术的术前影像学回顾性真实世界研究。
Sci Rep. 2022 Oct 19;12(1):17427. doi: 10.1038/s41598-022-18219-3.
3
Parathyroidectomy vs Cinacalcet Among Patients Undergoing Hemodialysis.
APPLICATION VALUE OF DISSECTION PARATHYROIDECTOMY IN PATIENTS WITH CHRONIC KIDNEY DISEASE COMPLICATED BY REFRACTORY SECONDARY HYPERPARATHYROIDISM.
解剖性甲状旁腺切除术在慢性肾脏病合并难治性继发性甲状旁腺功能亢进患者中的应用价值
Acta Endocrinol (Buchar). 2024 Jul-Sep;20(3):304-310. doi: 10.4183/aeb.2024.304. Epub 2025 May 23.
4
Bibliometric insights in surgical treatment of secondary hyperparathyroidism: Research status, hotspots, and global trends.继发性甲状旁腺功能亢进外科治疗的文献计量学见解:研究现状、热点及全球趋势
Medicine (Baltimore). 2025 Jun 6;104(23):e42033. doi: 10.1097/MD.0000000000042033.
5
Analysis of Factors Influencing Cardiovascular Events and Mortality in Patients on Dialysis after Parathyroidectomy.甲状旁腺切除术后透析患者心血管事件及死亡率的影响因素分析
Curr Pharm Des. 2025;31(33):2691-2704. doi: 10.2174/0113816128390373250507062606.
6
Combination Treatment With Intravenous and Oral Calcimimetics for Secondary Hyperparathyroidism in Hemodialysis Patients Who Decline Parathyroidectomy.静脉注射与口服拟钙剂联合治疗拒绝甲状旁腺切除术的血液透析患者继发性甲状旁腺功能亢进
Cureus. 2025 Mar 30;17(3):e81474. doi: 10.7759/cureus.81474. eCollection 2025 Mar.
7
Secondary hyperparathyroidism due to chronic kidney disease and access to clinical treatment and parathyroidectomy in Brazil: a nationwide survey.巴西慢性肾脏病所致继发性甲状旁腺功能亢进及临床治疗与甲状旁腺切除术的可及性:一项全国性调查
J Bras Nefrol. 2025 Apr-Jun;47(2):e20240158. doi: 10.1590/2175-8239-JBN-2024-0158en.
8
Lactobacillus johnsonii Generates Cyclo(pro-trp) and Promotes Intestinal Ca Absorption to Alleviate CKD-SHPT.约氏乳杆菌产生环(脯氨酸-色氨酸)并促进肠道钙吸收以减轻慢性肾脏病继发性甲状旁腺功能亢进。
Adv Sci (Weinh). 2025 Apr;12(16):e2414678. doi: 10.1002/advs.202414678. Epub 2025 Jan 31.
9
A Rare Presentation of Fahr's Syndrome Associated With Secondary Hyperparathyroidism.与继发性甲状旁腺功能亢进相关的法尔综合征的罕见表现。
Clin Case Rep. 2025 Jan 19;13(1):e70134. doi: 10.1002/ccr3.70134. eCollection 2025 Jan.
10
Effect of parathyroidectomy on serum inflammatory and metabolic dysfunction markers in patients with primary hyperparathyroidism.甲状旁腺切除术对原发性甲状旁腺功能亢进症患者血清炎症和代谢功能障碍标志物的影响。
Arch Endocrinol Metab. 2024 Nov 6;68:e240124. doi: 10.20945/2359-4292-2024-0124. eCollection 2024.
甲状旁腺切除术与西那卡塞在血液透析患者中的比较。
J Clin Endocrinol Metab. 2022 Jun 16;107(7):2016-2025. doi: 10.1210/clinem/dgac142.
4
A single-center experience of parathyroidectomy in 1500 cases for secondary hyperparathyroidism: a retrospective study.1500 例继发性甲状旁腺功能亢进症甲状旁腺切除术的单中心经验:一项回顾性研究。
Ren Fail. 2022 Dec;44(1):23-29. doi: 10.1080/0886022X.2021.2016445.
5
Hyperkalemia Following Parathyroidectomy in Patients with Renal Hyperparathyroidism-New Thresholds for Urgent Perioperative Dialysis.肾性甲状旁腺功能亢进患者甲状旁腺切除术后高钾血症——围手术期紧急透析的新阈值
J Clin Med. 2022 Jan 14;11(2):409. doi: 10.3390/jcm11020409.
6
Parathyroidectomy Versus Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients.甲状旁腺切除术与西那卡塞治疗血液透析患者继发性甲状旁腺功能亢进症的比较。
World J Surg. 2022 Apr;46(4):813-819. doi: 10.1007/s00268-022-06439-7. Epub 2022 Jan 12.
7
Independent effects of secondary hyperparathyroidism and hyperphosphataemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort.继发性甲状旁腺功能亢进和高磷血症对慢性肾脏病进展及心血管事件的独立影响:来自NEFRONA队列的分析
Nephrol Dial Transplant. 2022 Mar 25;37(4):663-672. doi: 10.1093/ndt/gfab184.
8
Intact parathyroid hormone levels localize causative glands in persistent or recurrent renal hyperparathyroidism: A retrospective cohort study.甲状旁腺激素水平完整可定位持续性或复发性肾性甲状旁腺功能亢进的致病腺体:一项回顾性队列研究。
PLoS One. 2021 Apr 1;16(4):e0248366. doi: 10.1371/journal.pone.0248366. eCollection 2021.
9
Control of hyperparathyroidism with the intravenous calcimimetic etelcalcetide in dialysis patients adherent and non-adherent to oral calcimimetics.在口服拟钙剂依从性和非依从性的透析患者中,使用静脉注射拟钙剂依特卡肽控制甲状旁腺功能亢进。
Clin Kidney J. 2020 Feb 12;14(3):840-846. doi: 10.1093/ckj/sfaa005. eCollection 2021 Mar.
10
Intraoperative recurrent laryngeal nerve monitoring using endotracheal electromyography during parathyroidectomy for secondary hyperparathyroidism.甲状旁腺切除术治疗继发性甲状旁腺功能亢进术中应用肌电图监测喉返神经。
J Int Med Res. 2021 Mar;49(3):3000605211000987. doi: 10.1177/03000605211000987.